MREO

Mereo BioPharma
MREO

Overview Fund Activity

79 hedge funds and large institutions have $362M invested in Mereo BioPharma in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 15 closing their positions.

Holders
79
Holders Change
-1
Holders Change %
-1.25%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
20
Reduced
27
Closed
15
Calls
$2.8M
Puts
$1.75M
Net Calls
+$1.05M
Net Calls Change
-$576K

Top Buyers

1
DM
1
Deerfield Management
New York
$24.2M
2
FLSM
2
Frazier Life Sciences Management
California
$15.8M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$28.4M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$42.4M
5
RCMNY
5
Rubric Capital Management (New York)
New York
$55.1M

Top Sellers

1
SCM
1
Suvretta Capital Management
New York
$270K
2
SCM
2
Soleus Capital Management
Connecticut
$4.49M
3
Morgan Stanley
3
Morgan Stanley
New York
$748K
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$3.02M
Name Market Value Shares Shares
Change 		Shares
Change %
RCMNY
1
Rubric Capital Management (New York)
New York
$55.1M 15,307,347 +1,754,350 +13%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$42.4M 11,791,310 +2,462,571 +26%
RSCM
3
Rock Springs Capital Management
Maryland
$33.4M 9,283,492 +1,141,383 +14%
MP
4
Mangrove Partners
Connecticut
$31.5M 8,752,893 – –
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$28.4M 7,880,882 +2,760,309 +54%
DM
6
Deerfield Management
New York
$24.2M 6,710,429 +6,710,429 New
6CM
7
683 Capital Management
New York
$18M 5,000,000 -750,000 -13%
Alkeon Capital Management
8
Alkeon Capital Management
New York
$16.9M 4,698,100 +460,000 +11%
FLSM
9
Frazier Life Sciences Management
California
$15.8M 4,401,371 +4,401,371 New
CC
10
Clearline Capital
New York
$12M 3,326,718 – –
Millennium Management
11
Millennium Management
New York
$11.5M 3,201,705 +1,022,570 +47%
TC
12
Tejara Capital
United Kingdom
$9.42M 2,615,458 +145,274 +6%
Goldman Sachs
13
Goldman Sachs
New York
$9.03M 2,507,513 +263,699 +12%
IHAM
14
Integral Health Asset Management
New York
$6.39M 1,775,000 +825,000 +87%
Renaissance Technologies
15
Renaissance Technologies
New York
$6.34M 1,762,003 +89,694 +5%
PA
16
Perceptive Advisors
New York
$4.51M 1,253,250 +1,253,250 New
SCM
17
Soleus Capital Management
Connecticut
$4.49M 1,246,953 -1,370,000 -52%
Marshall Wace
18
Marshall Wace
United Kingdom
$4.12M 1,144,051 +1,144,051 New
NIM
19
NEOS Investment Management
Connecticut
$3.45M 959,467 +336,037 +54%
BOCH
20
Blue Owl Capital Holdings
New York
$3.23M 897,809 +897,809 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$3.02M 840,264 -779,363 -48%
ACP
22
Acuta Capital Partners
California
$2.44M 677,000 +279,116 +70%
EP
23
Eversept Partners
New York
$1.79M 496,171 +496,171 New
AGP
24
Artia Global Partners
Florida
$1.52M 421,359 – –
Citadel Advisors
25
Citadel Advisors
Florida
$1.47M 408,989 +365,082 +831%
1
2 3 4